Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Type Psoriasis”

171 trials

Showing 20 of 171 results

Testing effectiveness (Phase 2)Study completedNCT00521339
What this trial is testing

Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis

Who this might be right for
Psoriasis-Type PsoriasisPlaque-Type Psoriasis
Amgen 31
Large-scale testing (Phase 3)Study completedNCT02016105
What this trial is testing

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira

Who this might be right for
Plaque Type Psoriasis
Sandoz 465
Large-scale testing (Phase 3)Study completedNCT00747344
What this trial is testing

Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 121
Large-scale testing (Phase 3)Study completedNCT01365455
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 738
Early research (Phase 1)Study completedNCT05522816
What this trial is testing

KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis

Who this might be right for
Psoriasis
PharmaEssentia 28
Post-approval studies (Phase 4)Study completedNCT01876875
What this trial is testing

N-3 Polysaturated Fatty Acids-rich Diet in Psoriasis

Who this might be right for
Plaque-type PsoriasisObesity (Body Mass Index >30 kg/m2)
Federico II University 44
Large-scale testing (Phase 3)Study completedNCT03721172
What this trial is testing

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

Who this might be right for
Psoriasis
Amgen 595
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT03504852
What this trial is testing

Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 331
Large-scale testing (Phase 3)Study completedNCT01555125
What this trial is testing

First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT01241591
What this trial is testing

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 1,101
Large-scale testing (Phase 3)WithdrawnNCT01936688
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Who this might be right for
Plaque-type Psoriasis
Sun Pharmaceutical Industries Limited
Testing effectiveness (Phase 2)Study completedNCT00759161
What this trial is testing

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Who this might be right for
Psoriasis
Pfizer 35
Post-approval studies (Phase 4)Study completedNCT04720105
What this trial is testing

Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis

Who this might be right for
Palmoplantar PsoriasisPlaque Psoriasis
Icahn School of Medicine at Mount Sinai 22
Testing effectiveness (Phase 2)Study completedNCT00823693
What this trial is testing

Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

Who this might be right for
Psoriasis
Revotar Biopharmaceuticals AG 107
Large-scale testing (Phase 3)Study completedNCT00723528
What this trial is testing

An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 158
Post-approval studies (Phase 4)Study completedNCT03440736
What this trial is testing

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

Who this might be right for
PsoriasisMetabolic Syndrome
Novartis Pharmaceuticals 781
Testing effectiveness (Phase 2)Study completedNCT01891019
What this trial is testing

Thalidomide in the Treatment of Chronic Plaque Psoriasis.

Who this might be right for
Psoriasis, Plaque-type
Wake Forest University 21
Testing effectiveness (Phase 2)Study completedNCT00941031
What this trial is testing

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 404
Testing effectiveness (Phase 2)Study completedNCT02432040
What this trial is testing

Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis

Who this might be right for
Psoriasis
Philippine Dermatological Society 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation